title: Metabolomics for rheumatic diseases: has the time come?
authors.affiliation: Inserm UMR 1125, Bobigny, France Sorbonne Paris Cité-Université Paris 13, Bobigny, France Assistance Publique-Hôpitaux de Paris (AP-HP) Groupe hospitalier Avicenne-Jean Verdier-René Muret, Service de Rhumatologie, Bobigny, France.
authors.forename: Luca
authors.initials: L
authors.lastname: Semerano
authors.affiliation: LRTS/DSV/CEA, UMR967, Inserm, CEA, Paris-Diderot, Paris-Sud, Fontenay-aux-Roses, Cedex, France.
authors.forename: Paul-Henri
authors.initials: PH
authors.lastname: Roméo
authors.affiliation: Inserm UMR 1125, Bobigny, France Sorbonne Paris Cité-Université Paris 13, Bobigny, France Assistance Publique-Hôpitaux de Paris (AP-HP) Groupe hospitalier Avicenne-Jean Verdier-René Muret, Service de Rhumatologie, Bobigny, France.
authors.forename: Marie-Christophe
authors.initials: MC
authors.lastname: Boissier
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000378:metabolism* / Q000517:prevention & control*; D002073:Butanes / Q000627:therapeutic use*; D002797:Choline Kinase / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D011726:Pyridinium Compounds / Q000627:therapeutic use*
chemical_list: D002073:Butanes; D004791:Enzyme Inhibitors; D011726:Pyridinium Compounds; D002797:Choline Kinase
keywords: Autoimmune Diseases; Autoimmunity; Inflammation; Rheumatoid Arthritis